CRYO-CELL INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value of $0.00 per share for the 6-month period ending 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue · last filed 2026-07-15
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2026-02-28 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2025-02-28 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2024-02-29 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2023-02-28 was $0.00, a 100.00% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2025 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2024 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2022 was $6.23.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-05-31 | $0.00 10-Q · filed 2026-07-15 | |||
| 2026-02-28 | $0.00 10-Q · filed 2026-04-14 | |||
| 2025-11-30 | $0.00 10-K · filed 2026-02-27 | |||
| 2025-08-31 | $0.00 10-Q · filed 2025-10-15 | |||
| 2025-05-31 | $0.00 10-Q · filed 2025-07-15 | |||
| 2025-02-28 | $0.00 10-Q · filed 2025-04-14 | |||
| 2024-11-30 | $0.00 10-K · filed 2025-02-28 | |||
| 2024-08-31 | $0.00 10-Q · filed 2024-10-15 | |||
| 2024-05-31 | $0.00 10-Q · filed 2024-07-15 | |||
| 2024-02-29 | $0.00 10-Q · filed 2024-04-15 | |||
| 2023-11-30 | $0.00 10-K · filed 2024-02-28 | |||
| 2023-08-31 | $0.00 10-Q · filed 2023-10-12 | |||
| 2023-05-31 | $0.00 10-Q · filed 2023-07-14 | |||
| 2023-02-28 | $0.00 10-Q · filed 2023-04-21 | |||
| 2022-11-30 | $6.23 10-K · filed 2023-02-28 | |||
| 2022-08-31 | $6.23 10-Q · filed 2022-10-18 | |||
| 2022-05-31 | $7.98 10-Q · filed 2022-07-11 | |||
| 2022-02-28 | $7.98 10-Q · filed 2022-04-13 | |||
| 2019-08-31 | $0.00 10-Q · filed 2019-10-15 | |||
| 2019-05-31 | $0.00 10-Q · filed 2019-07-15 | |||
| 2019-02-28 | $0.00 10-Q · filed 2019-04-15 | |||
| 2018-11-30 | $0.00 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |